Philogen S.p.A. (BIT:PHIL)
Italy
· Delayed Price · Currency is EUR 19.60
0.00 (0.00%)
Mar 31, 2025, 2:31 PM CET
Philogen Revenue
Philogen had revenue of 1.52M EUR in the half year ending June 30, 2024, a decrease of -92.43%. This brings the company's revenue in the last twelve months to 3.92M, down -86.59% year-over-year. In the year 2023, Philogen had annual revenue of 24.73M, down -8.20%.
Revenue (ttm)
3.92M
Revenue Growth
-86.59%
P/S Ratio
201.02
Revenue / Employee
22.52K
Employees
165
Market Cap
789.68M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 24.73M | -2.21M | -8.20% |
| Dec 31, 2022 | 26.94M | 21.98M | 442.71% |
| Dec 31, 2021 | 4.96M | -1.38M | -21.77% |
| Dec 31, 2020 | 6.35M | -8.71M | -57.85% |
| Dec 31, 2019 | 15.05M | -683.00K | -4.34% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.34B |
| DiaSorin | 1.19B |
| Amplifon | 2.41B |
| EL.En. | 565.85M |
| Pharmanutra | 116.15M |
| Garofalo Health Care | 470.71M |
| Safilo Group | 993.22M |
| GPI S.p.A. | 509.93M |